Humane Genomics logo

Humane Genomics

Platform to engineer cancer killing viruses using synthetic biology.

5 employees · est. 2019 · New York, United States

VS
ViraTherapeutics GmbH logo

ViraTherapeutics GmbH

We make cancer immunotherapies more powerful.

31 employees · est. 2013 · Innsbruck, Austria

ViraTherapeutics GmbH is the older company (2019 vs 2013); ViraTherapeutics GmbH is the larger of the two.

Side-by-Side Comparison

Humane Genomics ViraTherapeutics GmbH
Founded
2019 2013 older
Headquarters
New York, United States Innsbruck, Austria
Employees
5 31 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Series A
Total Funding
$125.00K $3.60M
Funding Rounds
3 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Synthetic Biology, Cancer Treatment, Virus Engineering, Startup, New York City, Investors, YC S21, Liver Cancer, Artificial Viruses, Viral Therapy Oncology, Immunotherapy, Oncolytic Viruses, Clinical Trials, Cancer Treatment, Drug Development, Patent Protection, Virotherapy, Cancer-killing Viruses, Medical Innovation
Website
humanegenomics.com viratherapeutics.com
Humane Genomics logo

About Humane Genomics

Humane Genomics is a biotechnology startup based in New York City that is focused on developing a platform to engineer cancer-killing viruses with unparalleled specificity and efficiency. Their innovative approach utilizes synthetic biology to target liver cancer as their initial indication. Since i...

ViraTherapeutics GmbH logo

About ViraTherapeutics GmbH

"Vira Therapeutics" is an Austrian biotechnology startup founded in 2015, with a focus on developing innovative oncology drugs utilizing cancer-killing viruses. The company's patented virus, designed for safety and efficacy, is poised to initiate clinical trials. Notably, "Vira Therapeutics" secured...

We will tell you when either one moves

BounceWatch watches Humane Genomics and ViraTherapeutics GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Humane Genomics and ViraTherapeutics GmbH — by email.

Frequently Asked Questions

Humane Genomics — Platform to engineer cancer killing viruses using synthetic biology.. ViraTherapeutics GmbH — We make cancer immunotherapies more powerful.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Humane Genomics has raised $125.00K while ViraTherapeutics GmbH has raised $3.60M.
Humane Genomics and ViraTherapeutics GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Humane Genomics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Humane Genomics on 13 Sep 2024, and ViraTherapeutics GmbH on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy